Corporate Governance
Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). Our lead product candidate is Altropane®, a proprietary molecular imaging agent used to diagnose Parkinson's disease and dementia. Altropane is presently in Phase III clinical development for the diagnosis of Parkinson's disease. Our development strategy for Altropane anticipates entering into one or more partnerships to ensure development and commercialization of the product.
| Document | View | ||
|---|---|---|---|
| Code of Business Conduct and Ethics |
51.0 KB
|
||
| Corporate Governance Guidlines |
59.3 KB
|
||
| Audit Committee Charter |
51.3 KB
|
||
